Potent and orally active inhibitor of the cytokines interleukin-12 (IL-12), and interleukin-23 (IL-23) production; potential regulators of certain autoimmune and inflammatory diseases. Blocks the translocation of c-Rel, a member of the Rel/NF-κB family of transcription factors, to the nucleus without affecting the translocation of the other NF-κB family members. It is also found to be a potent and selective PIKfyve inhibitor.
Apilimod dimesylate is the water soluble mesylate salt of Apilimod (Axon 1369).

Note: Apilimod (Axon 1369) or Apilimod dimesylate (Axon 2500) from Axon Medchem are fully QC-ed drug reference standards with approved bioactivities. Several prominent research laboratories have tested our samples with satisfactory testing results, evidenced by recent publications. There used to be the wrong isomer of Apilimod and its mesylate salt appeared on the reagent market from some other sources, which would be inactive in your assays. Be right about your drug!

KEYWORDS: Apilimod mesylate | supplier | IL-12/23 inhibitor | STA 5326 mesylate | STA5326 | CAS [870087-36-8] | [541550-19-0] | Interleukin | IL-12 | IL-23 | autoimmune | inflammation | translocation | c-Rel | NF-κB | transcription factor